CD147 as a novel receptor in the pathogenesis of SARS‐CoV ‐2: Is there any correlation with the risk of COVID ‐19 in dermatological diseases?
Author:
Affiliation:
1. Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
2. Clinical Research Development Unit Shohada‐e Tajrish Hospital, Shahid Beheshti University of Medical Sciences Tehran Iran
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14443
Reference10 articles.
1. COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review
2. CD147 as a target for COVID‐19 treatment: suggested effects of azithromycin and stem cell engagement;Ulrich H;Stem Cell Rev Rep,2020
3. Statins: Could an old friend help in the fight against COVID‐19?
4. Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors
5. Meplazumab treats COVID‐19 pneumonia: an open‐labelled, concurrent controlled add‐on clinical trial;Bian H;MedRxiv,2020
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation;Stem Cell Research & Therapy;2022-03-25
2. Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens;Dermatologic Therapy;2021-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3